Skip to main content
Clinical Trials/JPRN-UMIN000029895
JPRN-UMIN000029895
Not yet recruiting
Phase 2

A prospective study to verify the effectiveness of a element supplement "Elental" for patients who are administered TS-1 after surgical resection of pancreatic cancer - A prospective study to verify the effectiveness of a element supplement "Elental" for patients who are administered TS-1 after surgical resection of pancreatic cancer

Kobe University school of Medicine0 sites75 target enrollmentNovember 9, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Kobe University school of Medicine
Enrollment
75
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kobe University school of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion Criteria during hospital stay 1\)with active double cancer (\*) \*Simultaneous double cancer or sequential double cancer whose interstitial period is shorter than 5 years. Carcinoma in situ or cancers localized in membranous layer are not included to double cancer. Cancers removed by EMR/ESD are included. 2\)with a history of allergy against TS\-1 and/or Elental 3\)with active infection diseases 4\)with uncontrollable hypertension 5\)with uncontrollable DM 6\)with severe heart diseases clinically 7\)with severe lung diseases (interstitial pneumonitis,pulmonary fibrosis, or pulmonary emphysema) 8\)with psychologic diseases and/or psychological symptpms 9\)women pregnant and/or nursing or women who like to be pregnant 10\)patient registered to the other study whose endpoints are same to This study. 11\)patients whom doctor decide not to register to this study

Outcomes

Primary Outcomes

Not specified

Similar Trials